Medication Reconciliation in Chronic Pain Care Using Mass Spectrometry with Urine Specimens
Many patients being treated for chronic pain report concomitant symptoms, such as anxiety and depression, and are commonly treated by primary care physicians as well as specialists. Medication therapy often includes numerous pharmacologic agents in addition to opioids and are many times prescribed by different providers. These combinations may cause unintended drug-drug interactions and associated adverse drug events with serious consequences. Therefore, reconciliation of a patient’s medication use is essential to help minimize health risks and assure that patients receive the highest possible standard of care. The purpose of this retrospective analysis was to evaluate the results of urine drug tests of patients on chronic opioid therapy for prescribed and non-prescribed drugs in order to assist with accurate and specific medication reconciliation.